Wall Street Analysts See Upside Potential for 10 Stocks with Rising Price Targets

Page 8 of 8

01. Affimed N.V. (NASDAQ:AFMD)

Upside Potential: 257%

As of June 13, Laidlaw has increased Affimed N.V. (NASDAQ:AFMD) price target by $10 raising it from $15 to $25, highlighting a remarkable potential upside of 257%. This upward adjustment underscores Laidlaw’s strong confidence in Affimed N.V. (NASDAQ:AFMD) prospects for substantial growth within the biotechnology and pharmaceutical industry. The decision to raise the price target is supported by the company’s recent performance and anticipated financial advancements, including projected revenue growth and improved earnings per share (EPS).

Affimed N.V. (NASDAQ:AFMD) has garnered an average analyst rating of “Strong Buy,” with multiple analysts expressing high expectations for the stock’s trajectory. The consensus among analysts suggests significant upside potential, with price targets ranging from $10 to $70, indicating varying degrees of optimism about Affimed N.V. (NASDAQ:AFMD) future market performance. Laidlaw’s bullish outlook reflects their belief in Affimed N.V. (NASDAQ:AFMD) strategic initiatives and pipeline advancements, which are expected to drive future revenue streams and bolster shareholder value.

READ NEXT: Michael Burry Is Selling These Stocks and Jim Cramer is Recommending These Stocks.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below. You can also look at the Analysts are Upgrading These 10 AI Stocks and the 13 Best Quality Stocks To Buy.

Page 8 of 8